Building a National Pediatric Cancer Center and Network in Paraguay: Lessons for Addressing Challenges in a

Angélica Samudio1, Diego Figueredo, Alvaro Lassaletta

  • 1*Hospital de Clínicas, Facultad de Medicina, Universidad Nacional de Asunción, Asunción, Paraguay †Hospital Niño Jesús, Madrid, Spain ‡School of Public Health, The University of Memphis §Department of Oncology ∥International Outreach Program #Department of Infectious Diseases, St. Jude Children's Research Hospital **Department of Pediatrics, University of Tennessee Health Science Center, College of Medicine, Memphis, TN ¶Department of Pediatrics, Center of Biostatistics, University of Milan-Bicocca, San Gerardo Hospital, Monza, Italy.

Insights

Establishing Paraguay's first pediatric cancer center (PCC-SM) and a national network improved survival and reduced treatment abandonment for childhood acute lymphoblastic leukemia. This highlights the impact of increased access to specialized cancer care in low-resource settings.

Area of Science:

  • Oncology
  • Global Health
  • Pediatrics

Background:

  • Childhood cancer is a significant cause of mortality in Paraguay.
  • Limited access to specialized cancer care hinders pediatric patient outcomes.
  • The establishment of a national network and dedicated cancer center was crucial.

Purpose of the Study:

  • To detail the challenges and solutions in establishing Paraguay's first pediatric cancer center (PCC-SM).
  • To evaluate the outcomes of the National Network for Pediatric Cancer.
  • To identify strategies for improving pediatric cancer care in low-resource countries.

Main Methods:

  • Comparative analysis of treatment outcomes (survival rates, abandonment) before and after network establishment.
  • Description of the collaborative efforts involved in building the PCC-SM.
  • Analysis of the impact of increased treatment capacity.

Main Results:

  • Children with acute lymphoblastic leukemia treated post-network establishment (2008-2012) showed higher 3-year survival rates compared to the pre-network era (2000-2007).
  • Treatment abandonment rates decreased significantly after the PCC-SM's capacity increased.
  • Improvements correlated with the enhanced treatment capabilities of the PCC-SM.

Conclusions:

  • The development of the PCC-SM and National Network for Pediatric Cancer has demonstrably improved outcomes for childhood leukemia in Paraguay.
  • Expediting access to specialized diagnosis and care, alongside robust referral and follow-up systems, is key to improving pediatric cancer care globally.
  • International and national collaborations are vital for establishing and sustaining pediatric cancer centers in resource-limited settings.

Related Concept Videos

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.9K
Treatment Resistent Cancers02:56

Treatment Resistent Cancers

1.5K
Cancer Prevention02:59

Cancer Prevention

Several factors can increase the risk of cancer in an individual. About 50% of cancer cases can be prevented by adopting a healthy lifestyle, regular exercise, eating healthy, and following a modest cancer prevention diet. Epidemiological studies have consistently shown that populations with vegetable and fruit-rich diets have reduced the incidence of cancer. On the other hand, populations who have a diet rich in animal fat, red meat, junk food, or high calories are predisposed to cancer.
Some...
8.7K
Cancer Prevention02:59

Cancer Prevention

3.1K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
9.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

1.8K